COMP <GO>
IVF vs BJDX // EV/EBITDA & P/E VALUATION
INVO Fertility Inc. (NASDAQ) VS. Bluejay Diagnostics Inc. (NASDAQ) • 15-METRIC TALLY: IVF 2
— BJDX 1
■ METRIC PARITY
LAST: $0.54 (-3.60%) • MKT CAP: $2.5M
valuation
—
LAST: $0.54 (-5.08%) • MKT CAP: $2.4M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IVF VS. BJDX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IVF | BJDX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 68.00% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | 4.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 3/9 | +2.00 | IVF | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 26.0 | 29.6 | -3.60 | BJDX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.5M | $2.4M | $52.7K | IVF | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IVF REV | BJDX REV | IVF GROSS % | BJDX GROSS % | IVF FCF | BJDX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $6.8M | $0 | 98.0% | — | -$7.1M | -$6.2M |
| FY 2024 | $6.6M | $0 | 43.3% | — | -$3.2M | -$8.1M |
| FY 2023 | $3.0M | $0 | — | — | -$4.8M | -$8.3M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IVF // BETA —
BJDX // BETA —